Literature DB >> 5481239

L-dopa for postencephalitic Parkinsonism.

N Krasner, J M Cornelius.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 5481239      PMCID： PMC1820111          DOI： 10.1136/bmj.4.5733.496

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  2 in total

1.  L-dopa in postencephalitic parkinsonism.

Authors:  D B Calne; G M Stern; D R Laurence; J Sharkey; P Armitage
Journal:  Lancet       Date:  1969-04-12       Impact factor: 79.321

2.  [Disturbances of catecholamine metabolism (with special reference to dopamine) in the Parkinsonian syndrome].

Authors:  R Tissot
Journal:  Presse Med       Date:  1969-04-05       Impact factor: 1.228
  2 in total
  2 in total

Review 1.  Levodopa: a review of its pharmacological properties and therapeutic use with particular reference to Parkinsonism.

Authors:  R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1971       Impact factor: 9.546

2.  Response of patients with postencephalitic Parkinsonism to levodopa.

Authors:  R C Duvoisin; J Lobo-Antunes; M D Yahr
Journal:  J Neurol Neurosurg Psychiatry       Date:  1972-08       Impact factor: 10.154
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.